|
|
||||||||
The Journal of Immunology, Vol 157, Issue 11 5034-5041, Copyright © 1996 by American Association of Immunologists
ARTICLES |
JR Webb, D Kaufmann, A Campos-Neto and SG Reed
Infectious Disease Research Institute, Seattle, WA 98104, USA.
BALB/c mice are highly susceptible to infection with the protozoan parasite Leishmania major. This susceptibility has been attributed, in part, to the expansion of parasite-specific CD4+ Th2 cells that antagonize Th1 responses and promote humoral immunity. In the present study, we have utilized sera from L. major-infected BALB/c mice to screen an L. major amastigote cDNA expression library. One of the clones detected encodes a novel Ag designated as L. major stress- inducible 1 (LmSTI1). LmSTI1 contains six copies of the tetratricopeptide consensus motif and is highly related to a family of stress-inducible proteins that is conserved from yeast to humans. Sera from L. major-infected BALB/c mice have LmSTI1-specific Ab titers in excess of 1:200,000, comprised predominantly of IgG1, IgG2A, and IgG2B isotypes. Recombinant LmSTI1 protein elicited strong proliferative responses from draining lymph node cells of L. major-infected BALB/c mice at both early (10 days) and late (28 days) stages of infection and elicited production of high levels of IFN-gamma and low levels of IL-4. In contrast, soluble leishmanial lysate elicited high levels of IL-4 and low IFN-gamma production. Thus, we have identified an Ag of Leishmania capable of eliciting a mixed cellular response that is skewed toward a Th1 phenotype in susceptible BALB/c mice with advanced infections. In addition, analyses of sera from human patients with cutaneous, visceral, and post-kala azar visceral leishmaniasis indicated that a majority of individuals from all three clinical groups mounted strong humoral responses against LmSTI1.
This article has been cited by other articles:
![]() |
A. Badiee, M. R. Jaafari, A. Samiei, D. Soroush, and A. Khamesipour Coencapsulation of CpG Oligodeoxynucleotides with Recombinant Leishmania major Stress-Inducible Protein 1 in Liposome Enhances Immune Response and Protection against Leishmaniasis in Immunized BALB/c Mice Clin. Vaccine Immunol., April 1, 2008; 15(4): 668 - 674. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. N. Coler, Y. Goto, L. Bogatzki, V. Raman, and S. G. Reed Leish-111f, a Recombinant Polyprotein Vaccine That Protects against Visceral Leishmaniasis by Elicitation of CD4+ T Cells Infect. Immun., September 1, 2007; 75(9): 4648 - 4654. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Salay, M. L. Dorta, N. M. Santos, R. A. Mortara, C. Brodskyn, C. I. Oliveira, C. L. Barbieri, and M. M. Rodrigues Testing of Four Leishmania Vaccine Candidates in a Mouse Model of Infection with Leishmania (Viannia) braziliensis, the Main Causative Agent of Cutaneous Leishmaniasis in the New World Clin. Vaccine Immunol., September 1, 2007; 14(9): 1173 - 1181. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Campbell, V. Popov, and L. Soong Identification and Molecular Characterization of a Gene Encoding a Protective Leishmania amazonensis Trp-Asp (WD) Protein Infect. Immun., April 1, 2004; 72(4): 2194 - 2202. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. O. Odunuga, J. A. Hornby, C. Bies, R. Zimmermann, D. J. Pugh, and G. L. Blatch Tetratricopeptide Repeat Motif-mediated Hsc70-mSTI1 Interaction. MOLECULAR CHARACTERIZATION OF THE CRITICAL CONTACTS FOR SUCCESSFUL BINDING AND SPECIFICITY J. Biol. Chem., February 21, 2003; 278(9): 6896 - 6904. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Afrin, R. Rajesh, K. Anam, M. Gopinath, S. Pal, and N. Ali Characterization of Leishmania donovani Antigens Encapsulated in Liposomes That Induce Protective Immunity in BALB/c Mice Infect. Immun., December 1, 2002; 70(12): 6697 - 6706. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. N. Coler, Y. A. W. Skeiky, K. Bernards, K. Greeson, D. Carter, C. D. Cornellison, F. Modabber, A. Campos-Neto, and S. G. Reed Immunization with a Polyprotein Vaccine Consisting of the T-Cell Antigens Thiol-Specific Antioxidant, Leishmania major Stress-Inducible Protein 1, and Leishmania Elongation Initiation Factor Protects against Leishmaniasis Infect. Immun., August 1, 2002; 70(8): 4215 - 4225. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. G. Rhee, S. Mendez, J. A. Shah, C.-y. Wu, J. R. Kirman, T. N. Turon, D. F. Davey, H. Davis, D. M. Klinman, R. N. Coler, et al. Vaccination with Heat-killed Leishmania Antigen or Recombinant Leishmanial Protein and CpG Oligodeoxynucleotides Induces Long-Term Memory CD4+and CD8+T Cell Responses and Protection Against Leishmania major Infection J. Exp. Med., June 17, 2002; 195(12): 1565 - 1573. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Campos-Neto, J. R. Webb, K. Greeson, R. N. Coler, Y. A. W. Skeiky, and S. G. Reed Vaccination with Plasmid DNA Encoding TSA/LmSTI1 Leishmanial Fusion Proteins Confers Protection against Leishmania major Infection in Susceptible BALB/c Mice Infect. Immun., June 1, 2002; 70(6): 2828 - 2836. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Campos-Neto, R. Porrozzi, K. Greeson, R. N. Coler, J. R. Webb, Y. A. W. Seiky, S. G. Reed, and G. Grimaldi Jr. Protection against Cutaneous Leishmaniasis Induced by Recombinant Antigens in Murine and Nonhuman Primate Models of the Human Disease Infect. Immun., June 1, 2001; 69(6): 4103 - 4108. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mendez, S. Gurunathan, S. Kamhawi, Y. Belkaid, M. A. Moga, Y. A. W. Skeiky, A. Campos-Neto, S. Reed, R. A. Seder, and D. Sacks The Potency and Durability of DNA- and Protein-Based Vaccines Against Leishmania major Evaluated Using Low-Dose, Intradermal Challenge J. Immunol., April 15, 2001; 166(8): 5122 - 5128. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Probst, E. Stromberg, H. W. Ghalib, M. Mozel, R. Badaro, S. G. Reed, and J. R. Webb Identification and Characterization of T Cell-Stimulating Antigens from Leishmania by CD4 T Cell Expression Cloning J. Immunol., January 1, 2001; 166(1): 498 - 505. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Suffia, B. Ferrua, X. Stien, B. Mograbi, P. Marty, D. Rousseau, K. Fragaki, and J. Kubar A Novel Leishmania infantum Recombinant Antigen Which Elicits Interleukin 10 Production by Peripheral Blood Mononuclear Cells of Patients with Visceral Leishmaniasis Infect. Immun., February 1, 2000; 68(2): 630 - 636. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. A. W. Skeiky, M. Kennedy, D. Kaufman, M. M. Borges, J. A. Guderian, J. K. Scholler, P. J. Ovendale, K. S. Picha, P. J. Morrissey, K. H. Grabstein, et al. LeIF: A Recombinant Leishmania Protein That Induces an IL-12-Mediated Th1 Cytokine Profile J. Immunol., December 1, 1998; 161(11): 6171 - 6179. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Webb, A. Campos-Neto, P. J. Ovendale, T. I. Martin, E. J. Stromberg, R. Badaro, and S. G. Reed Human and Murine Immune Responses to a Novel Leishmania major Recombinant Protein Encoded by Members of a Multicopy Gene Family Infect. Immun., July 1, 1998; 66(7): 3279 - 3289. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |